Schizoaffective Disorders Terminated Phase 2 Trials for Rimonabant (DB06155)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00547118The Effects of Rimonabant, on Weight and Metabolic Risk FactorsTreatment